MedPath

The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy

Not Applicable
Conditions
Quality of Life
Bladder Cancer
Interventions
Device: provider monitoring and feedback to remote data
Device: participant monitoring of remote data
Registration Number
NCT06397040
Lead Sponsor
University of Pittsburgh
Brief Summary

Following radical cystectomy for bladder cancer, nearly two-thirds of patients experience a complication and almost a third are readmitted. Thus, intensified monitoring of this vulnerable group represents an opportunity for improved quality of care in the post-operative setting. By gathering biomarkers passively and continuously, wearable activity monitors augment remote patient monitoring. Further, they facilitate the collection of patient-reported outcomes frequently.

Despite the proven impact of remote monitoring on patient care, there is limited data on the feasibility and impact of employing this technology to trigger real-time provider assessment following cystectomy. The investigators plan to conduct a randomized control trial examining such. The intervention group of participants will receive continuous biomarker monitoring via FitBits and daily patient-reported outcome assessments via connected smartphones. Abnormalities in remote data will trigger automated alerts to providers. Providers will respond in real-time to these alerts and patients will receive education materials discussing preventative measures to mitigate the main risk factors for readmissions. The investigators will evaluate the feasibility of integrating this technology into the post-operative period, as well as the impact of real-time provider attention to abnormal remote data on patient-reported outcomes and rates of readmission. The investigators hypothesize that early assessment of and intervention on remote abnormalities will promote the use of outpatient or reduced intensity therapies, such as oral antibiotics or oral hydration, thus curtailing the severity of patient symptoms, intensity of complications, and need for hospitalizations. Ultimately, this trial builds upon prior research, applying patient-centered technology to improve the quality of care following cystectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
50
Inclusion Criteria
  • undergoing cystectomy at three hospitals within the University of Pittsburgh Medical Center system
  • English speaking
  • owns smart phone
Exclusion Criteria
  • unwilling or unable to participate
  • non-English speaking
  • does not own smart phone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
remote monitoring with provider feedbackparticipant monitoring of remote dataremote monitoring with FitBit device and daily patient-reported outcome assessment, as well as real-time provider feedback in response to remote data
remote monitoring without provider feedbackparticipant monitoring of remote dataremote monitoring with FitBit device and daily patient-reported outcome assessment, without real-time provider feedback
remote monitoring with provider feedbackprovider monitoring and feedback to remote dataremote monitoring with FitBit device and daily patient-reported outcome assessment, as well as real-time provider feedback in response to remote data
Primary Outcome Measures
NameTimeMethod
patient engagement4 weeks following hospital discharge

percent of patients who utilized the application daily and wore the device for 8hrs daily

provider response4 weeks following hospital discharge

time from alert to provider response to patient

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath